Rouvier Al‐Monajjed

About

Dr. Rouvier Al‐Monajjed is a urologic researcher whose work centers on improving surgical outcomes in prostate cancer through advanced imaging. His primary research focus is the integration of multiparametric magnetic resonance imaging (mpMRI) into pre-operative planning for robotic-assisted radical prostatectomy (RPE). In his highly cited 2022 study, "Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins," Dr. Al‐Monajjed demonstrated that 3T mpMRI can reliably identify patients at elevated risk for positive surgical margins (PSM)—a critical factor in cancer recurrence. This work, which has garnered 24 citations, provides surgeons with a non-invasive tool to tailor operative strategies and counsel patients more effectively. By establishing MRI-based risk predictors, his research bridges the gap between radiology and surgical oncology, offering a practical framework to reduce PSM rates. Dr. Al‐Monajjed’s contributions are particularly impactful for clinicians seeking to optimize patient selection and surgical precision, marking him as a rising voice in evidence-based urologic oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins

   24 citations · 2022

Key Collaborators

Contact & Links